Research dossier
Pinealon — neuronal regulatory tripeptide dossier
A tripeptide from the same research school as epitalon, studied on neuronal models.
Translated from the French original, which remains the reference version: lire en français →
Molecular identity
| Parameter | Value |
|---|---|
| CAS number | 175175-23-2 |
| Molar mass | 418.40 g/mol |
| Molecular formula | C₁₅H₂₆N₆O₈ |
| Sequence / nature | Glu-Asp-Arg |
| Purity | ≥99% |
| Appearance | White lyophilised powder |
The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.
Research context
The same research context as epitalon, with an even narrower body of work. The principal interest for a laboratory is comparative: having several peptides from the same series makes it possible to examine whether the reported effects vary with the sequence, which constitutes a minimal test of specificity.
Mechanism studied
Pinealon is a tripeptide of sequence Glu-Asp-Arg (EDR), belonging to the same family of short regulatory peptides as epitalon and arising from the same research programme.
The proposed mechanistic hypothesis is analogous: interaction with promoter DNA sequences and transcriptional modulation. The presence of an arginine gives the tripeptide a net positive charge at physiological pH, which is consistent with the hypothesis of an electrostatic interaction with the phosphate backbone of DNA.
The in-vitro work reported covers neuronal cultures exposed to oxidative stress or to oxygen-glucose deprivation, with cell viability, the expression of apoptosis markers and the quantification of reactive oxygen species by fluorescent probes as the measurements.
In-vitro literature
As with epitalon, a significant share of the publications is Russian-language and independent replication outside that setting remains limited. The primary neuronal culture protocols used vary appreciably between groups.
Bibliographic entry points
- PubMed — peer-reviewed literature
- PubChem — chemical profile and assay data
- NCBI — methodology and receptor references
These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.
Distinguishing this compound from its analogues
Sequence EDR, distinct from the AEDG of epitalon. The closeness of their publication context must not lead to transposing the results of one to the other.
The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.
Methodological limits
The same limits as epitalon as regards the accessibility of the literature. The primary neuronal culture models used vary widely — species, age, brain region — and those differences are enough to explain part of the variability between publications.
These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.
Analytical parameters
A highly polar tripeptide. The same chromatographic constraint as epitalon: low retention in reverse phase, requiring an adapted gradient.
| Parameter | Value |
|---|---|
| Storage | Store at −20 °C, protected from light |
| Solubility | Soluble in bacteriostatic water (BAC) |
| Stability | Stable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C |
| Control methods | RP-HPLC · MS · NMR |
Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.
Resulting concentrations
The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.
| Format | 1 ml | 2 ml | 3 ml |
|---|---|---|---|
| 10mg | 10.00 mg/ml | 5.00 mg/ml | 3.33 mg/ml |
| 20mg | 20.00 mg/ml | 10.00 mg/ml | 6.67 mg/ml |
These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.
Protocol design
Three points govern the validity of an assay using this material, whatever the question being asked.
The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.
The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.
The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.
Lot verification
The following formats are covered by a Janoshik Analytical report, readable from the product page:
- 10mg — lot report available
- 20mg — lot report available
| Format | Lot report | Availability |
|---|---|---|
| 20mg | Covered | In stock |
| 10mg | Covered | In stock |
| The verification programme covers exclusively the identity and purity of the material, by reverse-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic. |
Frequently asked questions
How does this product arrive?
As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.
Which solvent should be used for reconstitution?
Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.
How long does the material remain stable?
The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.
Does the analysis report correspond exactly to my vial?
The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.
Can this product be used on humans or animals?
No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.
Dossiers in the same category
- Epitalon — CAS 307297-39-8
- MOTS-c — CAS 1627580-64-6
- NAD+ — CAS 53-84-9
- SS-31 (Elamipretide) — CAS 736992-21-5